Azlocillin pharmacokinetics in patients with cystic fibrosis.

The pharmacokinetics of azlocillin were studied in 10 cystic fibrosis patients, ranging in age from 11 to 28 years. The patients received a 9- to 23-day course of 350 mg of azlocillin per kg in four or six divided daily doses in combination with am aminoglycoside. Blood and urine samples were collec...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bosso, J A, Saxon, B A, Herbst, J J, Matsen, J M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1984
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732230/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.630
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!